Table 1.

The distribution of patients, histopathological images/WSIs, and tiles in each subset.

	Patients				Histopathological images				Tiles
	Tr	Te	IV	EV	Tr	Te	IV	EV	Tr	Te	IV	EV
Normal and HCC
HCC	208	41	128	67	225	47	130	67	41,578	8157	24,294	13,393
Normal	53	9	27	34	53	9	27	34	12,614	2204	9493	7863
Histopathological grade
Well (G1)	31	7	14	17	33	8	14	17	6967	1893	2654	3199
Moderate (G2)	98	17	60	38	106	20	61	38	18,754	3862	10,953	7801
Poor (G3/G4)	69	14	48	12	76	16	49	12	13,701	3189	8783	2393
CTNNB1 mutation
Yes	60	13	26	21	63	15	26	21	11,283	3218	5329	4120
No	142	29	96	46	153	32	98	46	28,437	6321	18,342	9273
FMN2 mutation
Yes	31	7	9	10	32	7	9	10	6335	1632	2143	2736
No	171	35	113	57	184	40	115	57	34,103	7963	20,754	10,657
TP53 mutation
Yes	64	14	42	20	68	14	43	20	12,537	2873	7794	4341
No	138	28	80	47	148	33	81	47	26,521	6359	16,646	9052
ZFX4 mutation
Yes	35	5	20	15	36	6	20	15	7273	1468	3892	3224
No	167	37	102	52	180	41	104	52	33,219	7845	19,233	10,169

Tr training subset, Te test subset, IV internal validation subset, EV external validation subset.